speb/financial-data huggingface dataset:
EXE balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 2333000000.00
EXE income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 3142000000.00
EXE balance_sheet (annual, 2023-12-31) — Total Tax Payable: 84000000.00
EXE income_statement (annual, 2023-12-31) — Total Unusual Items: 774000000.00
EXE income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 774000000.00
EXE balance_sheet (annual, 2023-12-31) — Working Capital: 1295000000.00
EXE income_statement (quarterly, 2024-09-30) — Interest Income: 3000000.00
EXE income_statement (quarterly, 2024-09-30) — Interest Income Non Operating: 3000000.00
EXE cash_flow (quarterly, 2024-09-30) — Net Other Financing Charges: 0.00
EXE income_statement (annual, 2024-12-31) — +Operating Expense: 1838000000.00
EXE income_statement (annual, 2024-12-31) — +Total Revenue: 4221000000.00
EXE balance_sheet (annual, 2024-12-31) — Accounts Payable: 777000000.00
EXE balance_sheet (annual, 2024-12-31) — Accounts Receivable: 1028000000.00
EXE balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -5362000000.00
EXE balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 13687000000.00
EXE income_statement (annual, 2024-12-31) — Basic Average Shares: 156989000.00
EXE income_statement (annual, 2024-12-31) — Basic EPS: -4.55
EXE cash_flow (annual, 2024-12-31) — Beginning Cash Position: 1153000000.00
EXE balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 329000000.00
EXE balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 329000000.00
EXE cash_flow (annual, 2024-12-31) — Capital Expenditure: -1557000000.00
EXE cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -1557000000.00
EXE balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 71000000.00
EXE balance_sheet (annual, 2024-12-31) — Capital Stock: 2000000.00
EXE balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 317000000.00
EXE balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 317000000.00
EXE cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -388000000.00
EXE balance_sheet (annual, 2024-12-31) — Cash Financial: 317000000.00
EXE balance_sheet (quarterly, 2024-12-31) — Cash Financial: 317000000.00
EXE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -419000000.00
EXE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -1904000000.00
EXE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 1565000000.00
EXE cash_flow (annual, 2024-12-31) — Change In Working Capital: -315000000.00
EXE cash_flow (annual, 2024-12-31) — Changes In Cash: -758000000.00
EXE balance_sheet (annual, 2024-12-31) — Common Stock: 2000000.00
EXE cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -388000000.00
EXE balance_sheet (annual, 2024-12-31) — Common Stock Equity: 17565000000.00
EXE cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
EXE income_statement (annual, 2024-12-31) — Cost Of Revenue: 3080000000.00
EXE balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 396000000.00
EXE balance_sheet (annual, 2024-12-31) — Current Assets: 1997000000.00
EXE balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 71000000.00
EXE balance_sheet (annual, 2024-12-31) — Current Debt: 389000000.00
EXE balance_sheet (quarterly, 2024-12-31) — Current Debt: 389000000.00
EXE balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 460000000.00
EXE balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 297000000.00
EXE balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 297000000.00
EXE balance_sheet (annual, 2024-12-31) — Current Liabilities: 3123000000.00
EXE cash_flow (annual, 2024-12-31) — Deferred Income Tax: -123000000.00
EXE cash_flow (annual, 2024-12-31) — Deferred Tax: -123000000.00
EXE cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 1729000000.00
EXE balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 68000000.00
EXE income_statement (annual, 2024-12-31) — Diluted Average Shares: 156989000.00
EXE income_statement (annual, 2024-12-31) — Diluted EPS: -4.55
EXE income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -714000000.00
EXE balance_sheet (annual, 2024-12-31) — Duefrom Related Parties Current: 191000000.00
EXE income_statement (annual, 2024-12-31) — EBIT: -711000000.00
EXE income_statement (annual, 2024-12-31) — EBITDA: 1018000000.00
EXE cash_flow (annual, 2024-12-31) — End Cash Position: 395000000.00
EXE balance_sheet (annual, 2024-12-31) — Financial Assets: 1000000.00
EXE cash_flow (annual, 2024-12-31) — Financing Cash Flow: -419000000.00
EXE cash_flow (annual, 2024-12-31) — Free Cash Flow: 8000000.00
EXE cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 38000000.00
EXE income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 14000000.00
EXE income_statement (annual, 2024-12-31) — General And Administrative Expense: 186000000.00
EXE balance_sheet (annual, 2024-12-31) — Gross PPE: 29644000000.00
EXE income_statement (annual, 2024-12-31) — Gross Profit: 1141000000.00
EXE balance_sheet (annual, 2024-12-31) — Hedging Assets Current: 84000000.00
EXE income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
EXE income_statement (annual, 2024-12-31) — Interest Expense: 130000000.00
EXE income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 130000000.00
EXE income_statement (annual, 2024-12-31) — Interest Income: 7000000.00
EXE income_statement (quarterly, 2024-12-31) — Interest Income: -1000000.00
EXE income_statement (annual, 2024-12-31) — Interest Income Non Operating: 7000000.00
EXE income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: -1000000.00
EXE cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 93000000.00
EXE balance_sheet (annual, 2024-12-31) — Interest Payable: 100000000.00
EXE balance_sheet (annual, 2024-12-31) — Invested Capital: 23245000000.00
EXE cash_flow (annual, 2024-12-31) — Investing Cash Flow: -1904000000.00
EXE cash_flow (annual, 2024-12-31) — Issuance Of Debt: 767000000.00
EXE balance_sheet (annual, 2024-12-31) — Land And Improvements: 29000000.00
EXE balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 29000000.00
EXE balance_sheet (annual, 2024-12-31) — Line Of Credit: 0.00
EXE balance_sheet (quarterly, 2024-12-31) — Line Of Credit: 0.00
EXE balance_sheet (annual, 2024-12-31) — Long Term Debt: 5291000000.00
EXE balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 5291000000.00
EXE cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 767000000.00
EXE cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -787000000.00
EXE balance_sheet (annual, 2024-12-31) — Long Term Provisions: 499000000.00
EXE balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 150000000.00
EXE balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 150000000.00
EXE cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -459000000.00
EXE cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
EXE balance_sheet (annual, 2024-12-31) — Net Debt: 5363000000.00
EXE income_statement (annual, 2024-12-31) — Net Income: -714000000.00
EXE income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -714000000.00
EXE income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -714000000.00
EXE income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -714000000.00
EXE income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -714000000.00
EXE cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -714000000.00
EXE income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -714000000.00
EXE income_statement (annual, 2024-12-31) — Net Interest Income: -123000000.00
EXE cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -75000000.00
EXE cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -20000000.00
EXE cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -20000000.00
EXE income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -123000000.00
EXE cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -14000000.00
EXE cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -10000000.00
EXE cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 166000000.00
EXE balance_sheet (annual, 2024-12-31) — Net PPE: 24282000000.00
EXE cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 21000000.00
EXE balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 17565000000.00
EXE balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 589000000.00
EXE balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 1227000000.00
EXE balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 1227000000.00
EXE balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 589000000.00
EXE income_statement (annual, 2024-12-31) — Normalized EBITDA: 1125000000.00
EXE income_statement (annual, 2024-12-31) — Normalized Income: -623157000.00
EXE cash_flow (annual, 2024-12-31) — Operating Cash Flow: 1565000000.00
EXE cash_flow (annual, 2024-12-31) — Operating Gains Losses: 25000000.00
EXE income_statement (annual, 2024-12-31) — Operating Income: -697000000.00
EXE income_statement (annual, 2024-12-31) — Operating Revenue: 4221000000.00
EXE balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 231769886.00
EXE balance_sheet (annual, 2024-12-31) — Other Current Assets: 292000000.00
EXE balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 389000000.00
EXE balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 389000000.00
EXE balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 193000000.00
EXE income_statement (annual, 2024-12-31) — Other Gand A: 186000000.00
EXE income_statement (annual, 2024-12-31) — Other Income Expense: -21000000.00
EXE cash_flow (annual, 2024-12-31) — Other Non Cash Items: 925000000.00
EXE balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 1025000000.00
EXE balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 121000000.00
EXE income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 86000000.00
EXE income_statement (annual, 2024-12-31) — Other Operating Expenses: 342000000.00
EXE balance_sheet (annual, 2024-12-31) — Other Payable: 734000000.00
EXE balance_sheet (annual, 2024-12-31) — Other Properties: 146000000.00
EXE balance_sheet (annual, 2024-12-31) — Other Receivables: 18000000.00
EXE income_statement (annual, 2024-12-31) — Other Special Charges: 1000000.00
EXE income_statement (quarterly, 2024-12-31) — Other Special Charges: -1000000.00
EXE income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
EXE balance_sheet (annual, 2024-12-31) — Payables: 1653000000.00
EXE balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 2049000000.00
EXE balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 124000000.00
EXE income_statement (annual, 2024-12-31) — Pretax Income: -841000000.00
EXE cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 3000000.00
EXE cash_flow (annual, 2024-12-31) — Purchase Of Business: -459000000.00
EXE cash_flow (annual, 2024-12-31) — Purchase Of Investment: -75000000.00
EXE cash_flow (annual, 2024-12-31) — Purchase Of PPE: 0.00
EXE balance_sheet (annual, 2024-12-31) — Receivables: 1226000000.00
EXE balance_sheet (annual, 2024-12-31) — Receivables Adjustments Allowances: -11000000.00
EXE income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 3080000000.00
EXE income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1729000000.00
EXE cash_flow (annual, 2024-12-31) — Repayment Of Debt: -787000000.00
EXE cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
EXE balance_sheet (annual, 2024-12-31) — Restricted Cash: 78000000.00
EXE income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 120000000.00
EXE balance_sheet (annual, 2024-12-31) — Retained Earnings: 3876000000.00
EXE cash_flow (annual, 2024-12-31) — Sale Of PPE: 21000000.00
EXE income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 1310000000.00
EXE income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 654000000.00
EXE income_statement (annual, 2024-12-31) — Selling General And Administration: 1496000000.00
EXE balance_sheet (annual, 2024-12-31) — Share Issued: 231769886.00
EXE income_statement (annual, 2024-12-31) — Special Income Charges: -107000000.00
EXE cash_flow (annual, 2024-12-31) — Stock Based Compensation: 38000000.00
EXE balance_sheet (annual, 2024-12-31) — Stockholders Equity: 17565000000.00
EXE balance_sheet (annual, 2024-12-31) — Tangible Book Value: 17565000000.00
EXE income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -16157000.00
EXE income_statement (annual, 2024-12-31) — Tax Provision: -127000000.00
EXE income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.15
EXE balance_sheet (annual, 2024-12-31) — Total Assets: 27894000000.00
EXE balance_sheet (annual, 2024-12-31) — Total Capitalization: 22856000000.00
EXE balance_sheet (annual, 2024-12-31) — Total Debt: 5751000000.00
EXE balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 17565000000.00
EXE income_statement (annual, 2024-12-31) — Total Expenses: 4918000000.00
EXE balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 10329000000.00
EXE balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 25897000000.00
EXE balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 7206000000.00
EXE income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -803000000.00
EXE balance_sheet (annual, 2024-12-31) — Total Tax Payable: 142000000.00
EXE income_statement (annual, 2024-12-31) — Total Unusual Items: -107000000.00
EXE income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -107000000.00
EXE balance_sheet (annual, 2024-12-31) — Working Capital: -1126000000.00
EXE income_statement (quarterly, 2025-03-31) — +Operating Expense: 995000000.00
EXE income_statement (quarterly, 2025-03-31) — +Total Revenue: 2196000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 654000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1137000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -6066000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 13700000000.00
EXE income_statement (quarterly, 2025-03-31) — Basic Average Shares: 234434000.00
EXE income_statement (quarterly, 2025-03-31) — Basic EPS: -1.06
EXE cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 395000000.00
EXE cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -563000000.00
EXE cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -563000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 71000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 349000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 349000000.00
EXE cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -142000000.00
EXE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -557000000.00
EXE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -507000000.00
EXE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 1096000000.00
EXE cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -251000000.00
EXE cash_flow (quarterly, 2025-03-31) — Changes In Cash: 32000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Common Stock: 2000000.00
EXE cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -142000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 17191000000.00
EXE cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
EXE income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1421000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 534000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Current Assets: 2113000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 71000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 71000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 288000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 288000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 3589000000.00
EXE cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -37000000.00
EXE cash_flow (quarterly, 2025-03-31) — Deferred Tax: -37000000.00
EXE cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 711000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 129000000.00
EXE income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 234434000.00
EXE income_statement (quarterly, 2025-03-31) — Diluted EPS: -1.06
EXE income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -249000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Duefrom Related Parties Current: 228000000.00
EXE income_statement (quarterly, 2025-03-31) — EBIT: -260000000.00
EXE income_statement (quarterly, 2025-03-31) — EBITDA: 451000000.00
EXE cash_flow (quarterly, 2025-03-31) — End Cash Position: 427000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Financial Assets: 2000000.00
EXE cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -557000000.00
EXE cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 533000000.00
EXE cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 1014000000.00
EXE income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: 0.00
EXE income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 47000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Gross PPE: 30326000000.00
EXE income_statement (quarterly, 2025-03-31) — Gross Profit: 775000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 0.00
EXE cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 0.00
EXE income_statement (quarterly, 2025-03-31) — Interest Expense: 59000000.00
EXE income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 59000000.00
EXE income_statement (quarterly, 2025-03-31) — Interest Income: 0.00
EXE income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 0.00
EXE cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 91000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Interest Payable: 68000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Invested Capital: 22434000000.00
EXE cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -507000000.00
EXE cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 725000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 5243000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 5243000000.00
EXE cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 725000000.00
EXE cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -1161000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 506000000.00
EXE cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
EXE balance_sheet (quarterly, 2025-03-31) — Net Debt: 4894000000.00
EXE income_statement (quarterly, 2025-03-31) — Net Income: -249000000.00
EXE income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -249000000.00
EXE income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -249000000.00
EXE income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -249000000.00
EXE income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -249000000.00
EXE cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -249000000.00
EXE income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -249000000.00
EXE income_statement (quarterly, 2025-03-31) — Net Interest Income: -59000000.00
EXE cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -4000000.00
EXE cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -436000000.00
EXE cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -436000000.00
EXE income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -59000000.00
EXE cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 60000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Net PPE: 24260000000.00
EXE cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 0.00
EXE balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 17191000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 626000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 1159000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 1159000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 626000000.00
EXE income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 499000000.00
EXE income_statement (quarterly, 2025-03-31) — Normalized Income: -211512000.00
EXE cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 1096000000.00
EXE cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 1014000000.00
EXE income_statement (quarterly, 2025-03-31) — Operating Income: -220000000.00
EXE income_statement (quarterly, 2025-03-31) — Operating Revenue: 2196000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 237476127.00
EXE balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 325000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 998000000.00
EXE income_statement (quarterly, 2025-03-31) — Other Gand A: 47000000.00
EXE income_statement (quarterly, 2025-03-31) — Other Income Expense: -40000000.00
EXE cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -101000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 933000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 117000000.00
EXE income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 8000000.00
EXE income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 29000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Other Payable: 892000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Other Properties: 678000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Other Receivables: 12000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Payables: 1650000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 2184000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 48000000.00
EXE income_statement (quarterly, 2025-03-31) — Pretax Income: -319000000.00
EXE cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 21000000.00
EXE cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -4000000.00
EXE cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: 0.00
EXE balance_sheet (quarterly, 2025-03-31) — Receivables: 1361000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Receivables Adjustments Allowances: -16000000.00
EXE income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1421000000.00
EXE income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 711000000.00
EXE cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -1161000000.00
EXE cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
EXE balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 78000000.00
EXE income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 48000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 3489000000.00
EXE cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
EXE cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
EXE income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 919000000.00
EXE income_statement (quarterly, 2025-03-31) — Selling General And Administration: 966000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Share Issued: 237476127.00
EXE income_statement (quarterly, 2025-03-31) — Special Income Charges: -48000000.00
EXE cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 9000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 17191000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 17191000000.00
EXE income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -10512000.00
EXE income_statement (quarterly, 2025-03-31) — Tax Provision: -70000000.00
EXE income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.22
EXE balance_sheet (quarterly, 2025-03-31) — Total Assets: 27934000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 22434000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Total Debt: 5314000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 17191000000.00
EXE income_statement (quarterly, 2025-03-31) — Total Expenses: 2416000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 10743000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 25821000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 7154000000.00
EXE income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -268000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 104000000.00
EXE income_statement (quarterly, 2025-03-31) — Total Unusual Items: -48000000.00
EXE income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -48000000.00
EXE balance_sheet (quarterly, 2025-03-31) — Working Capital: -1476000000.00
EXE income_statement (quarterly, 2025-06-30) — +Operating Expense: 98000000.00
EXE income_statement (quarterly, 2025-06-30) — +Total Revenue: 3686000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 747000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 837000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -6825000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 13716000000.00
EXE income_statement (quarterly, 2025-06-30) — Basic Average Shares: 237973000.00
EXE income_statement (quarterly, 2025-06-30) — Basic EPS: 4.07
EXE cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 427000000.00
EXE cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -657000000.00
EXE cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -657000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 67000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Capital Stock: 2000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 731000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 731000000.00
EXE cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -137000000.00
EXE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -352000000.00
EXE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -591000000.00
EXE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 1322000000.00
EXE cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 321000000.00
EXE cash_flow (quarterly, 2025-06-30) — Changes In Cash: 379000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Common Stock: 2000000.00
EXE cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -137000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 17937000000.00
EXE cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -99000000.00
EXE income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2274000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 508000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Current Assets: 2272000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 67000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 67000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 286000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 286000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 2924000000.00
EXE cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 171000000.00
EXE cash_flow (quarterly, 2025-06-30) — Deferred Tax: 171000000.00
EXE cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 769000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 85000000.00
EXE income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 240560000.00
EXE income_statement (quarterly, 2025-06-30) — Diluted EPS: 4.02
EXE income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 968000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Duefrom Related Parties Current: 220000000.00
EXE income_statement (quarterly, 2025-06-30) — EBIT: 1288000000.00
EXE income_statement (quarterly, 2025-06-30) — EBITDA: 2057000000.00
EXE cash_flow (quarterly, 2025-06-30) — End Cash Position: 806000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Financial Assets: 13000000.00
EXE cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -352000000.00
EXE cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 665000000.00
EXE cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -877000000.00
EXE income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: 4000000.00
EXE income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 40000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Gross PPE: 30997000000.00
EXE income_statement (quarterly, 2025-06-30) — Gross Profit: 1412000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Hedging Assets Current: 46000000.00
EXE cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 82000000.00
EXE income_statement (quarterly, 2025-06-30) — Interest Expense: 60000000.00
EXE income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 60000000.00
EXE cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 19000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Interest Payable: 107000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Invested Capital: 23059000000.00
EXE cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -591000000.00
EXE cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 100000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Line Of Credit: 0.00
EXE balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 5122000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 5122000000.00
EXE cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 100000000.00
EXE cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: 336000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 513000000.00
EXE cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -99000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Net Debt: 4391000000.00
EXE income_statement (quarterly, 2025-06-30) — Net Income: 968000000.00
EXE income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 968000000.00
EXE income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 968000000.00
EXE income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 968000000.00
EXE income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 968000000.00
EXE cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 968000000.00
EXE income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 968000000.00
EXE income_statement (quarterly, 2025-06-30) — Net Interest Income: -60000000.00
EXE cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -5000000.00
EXE cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 436000000.00
EXE cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 436000000.00
EXE income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -60000000.00
EXE cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 56000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Net PPE: 24172000000.00
EXE cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 15000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 17937000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 457000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 1083000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 1083000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 457000000.00
EXE income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 2099000000.00
EXE income_statement (quarterly, 2025-06-30) — Normalized Income: 1001107491.86
EXE cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 1322000000.00
EXE cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -884000000.00
EXE income_statement (quarterly, 2025-06-30) — Operating Income: 1314000000.00
EXE income_statement (quarterly, 2025-06-30) — Operating Revenue: 3686000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 237437223.00
EXE balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 346000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 266000000.00
EXE income_statement (quarterly, 2025-06-30) — Other Gand A: 40000000.00
EXE income_statement (quarterly, 2025-06-30) — Other Income Expense: -26000000.00
EXE cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -36000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 854000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 104000000.00
EXE income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 16000000.00
EXE income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 58000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Other Payable: 814000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Other Properties: 679000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Other Receivables: 32000000.00
EXE income_statement (quarterly, 2025-06-30) — Other Special Charges: -3000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Payables: 1724000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 2232000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 73000000.00
EXE income_statement (quarterly, 2025-06-30) — Pretax Income: 1228000000.00
EXE cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 1000000.00
EXE cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -5000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Receivables: 1074000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Receivables Adjustments Allowances: -15000000.00
EXE income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2274000000.00
EXE income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 769000000.00
EXE cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: 336000000.00
EXE cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -99000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 75000000.00
EXE income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 49000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 4219000000.00
EXE cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 15000000.00
EXE income_statement (quarterly, 2025-06-30) — Selling General And Administration: 40000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Share Issued: 237437223.00
EXE income_statement (quarterly, 2025-06-30) — Special Income Charges: -42000000.00
EXE cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 13000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 17937000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 17937000000.00
EXE income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -8892508.14
EXE income_statement (quarterly, 2025-06-30) — Tax Provision: 260000000.00
EXE income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
EXE balance_sheet (quarterly, 2025-06-30) — Total Assets: 27768000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 23059000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Total Debt: 5189000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 17937000000.00
EXE income_statement (quarterly, 2025-06-30) — Total Expenses: 2372000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 9831000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 25496000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 6907000000.00
EXE income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 1269000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 163000000.00
EXE income_statement (quarterly, 2025-06-30) — Total Unusual Items: -42000000.00
EXE income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -42000000.00
EXE balance_sheet (quarterly, 2025-06-30) — Working Capital: -652000000.00
EXE income_statement (quarterly, 2025-09-30) — +Operating Expense: 670000000.00
EXE income_statement (quarterly, 2025-09-30) — +Total Revenue: 2967000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 830000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 743000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -7559000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 13733000000.00
EXE income_statement (quarterly, 2025-09-30) — Basic Average Shares: 238221000.00
EXE income_statement (quarterly, 2025-09-30) — Basic EPS: 2.30
EXE cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 806000000.00
EXE cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -844000000.00
EXE cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -775000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 63000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Capital Stock: 2000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 613000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 613000000.00
EXE cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -349000000.00
EXE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -471000000.00
EXE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -845000000.00
EXE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 1201000000.00
EXE cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 72000000.00
EXE cash_flow (quarterly, 2025-09-30) — Changes In Cash: -115000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Common Stock: 2000000.00
EXE cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -349000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 18150000000.00
EXE cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -1000000.00
EXE income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1518000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 424000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Current Assets: 2241000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 63000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 63000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 271000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 271000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 2766000000.00
EXE cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 186000000.00
EXE cash_flow (quarterly, 2025-09-30) — Deferred Tax: 186000000.00
EXE cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 741000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 27000000.00
EXE income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 239893000.00
EXE income_statement (quarterly, 2025-09-30) — Diluted EPS: 2.28
EXE income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 547000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Duefrom Related Parties Current: 258000000.00
EXE income_statement (quarterly, 2025-09-30) — EBIT: 743000000.00
EXE income_statement (quarterly, 2025-09-30) — EBITDA: 1484000000.00
EXE cash_flow (quarterly, 2025-09-30) — End Cash Position: 691000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Financial Assets: 10000000.00
EXE cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -471000000.00
EXE cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 357000000.00
EXE cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -451000000.00
EXE income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: -1000000.00
EXE income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 45000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Gross PPE: 31795000000.00
EXE income_statement (quarterly, 2025-09-30) — Gross Profit: 1449000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Hedging Assets Current: 157000000.00
EXE cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: -15000000.00
EXE income_statement (quarterly, 2025-09-30) — Interest Expense: 57000000.00
EXE income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 57000000.00
EXE cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 105000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Interest Payable: 57000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Invested Capital: 23160000000.00
EXE cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -845000000.00
EXE cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
EXE balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 0.00
EXE balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 5010000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 5010000000.00
EXE cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
EXE cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: 0.00
EXE balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 525000000.00
EXE cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -1000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Net Debt: 4397000000.00
EXE income_statement (quarterly, 2025-09-30) — Net Income: 547000000.00
EXE income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 547000000.00
EXE income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 547000000.00
EXE income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 547000000.00
EXE income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 547000000.00
EXE cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 547000000.00
EXE income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 547000000.00
EXE income_statement (quarterly, 2025-09-30) — Net Interest Income: -57000000.00
EXE cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -5000000.00
EXE cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
EXE cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
EXE income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -57000000.00
EXE cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -121000000.00
EXE cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 0.00
EXE balance_sheet (quarterly, 2025-09-30) — Net PPE: 24236000000.00
EXE cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -65000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 18150000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 273000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 1027000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 1027000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 273000000.00
EXE income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 1537000000.00
EXE income_statement (quarterly, 2025-09-30) — Normalized Income: 589260932.94
EXE cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 1201000000.00
EXE cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -451000000.00
EXE income_statement (quarterly, 2025-09-30) — Operating Income: 779000000.00
EXE income_statement (quarterly, 2025-09-30) — Operating Revenue: 2967000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 238150070.00
EXE balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 367000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 117000000.00
EXE income_statement (quarterly, 2025-09-30) — Other Gand A: 45000000.00
EXE income_statement (quarterly, 2025-09-30) — Other Income Expense: -36000000.00
EXE cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 94000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 846000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 101000000.00
EXE income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 17000000.00
EXE income_statement (quarterly, 2025-09-30) — Other Operating Expenses: -34000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Other Payable: 808000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Other Properties: 702000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Other Receivables: 38000000.00
EXE income_statement (quarterly, 2025-09-30) — Other Special Charges: -1000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Payables: 1807000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 2231000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 84000000.00
EXE income_statement (quarterly, 2025-09-30) — Pretax Income: 686000000.00
EXE cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
EXE cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -5000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Receivables: 1026000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Receivables Adjustments Allowances: -13000000.00
EXE income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1518000000.00
EXE income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 741000000.00
EXE cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 0.00
EXE cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -1000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 78000000.00
EXE income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 53000000.00